HOME    | Hepatitis B     | Hepatitis C  
<--- Return to the 56th AASLD Main Page
HIVandHepatitis.com Coverage of Highlights from the
56th Annual Meeting of the American
Association for the Study of Liver Diseases
 November 11 - 15, 2005 San Francisco, California


Super Responders / Nonresponders

Safety and Efficacy of Pegasys Plus Ribavirin in HCV Patients Intolerant or Nonresponsive to Treatment with PegIntron Plus Ribavirin - 11/23/05

Do Higher Doses of Anti-HCV Treatment Increase Responses?: A Tale of 3 Studies - 11/21/05

Albuferon Plus Ribavirin in Nonresponders to Interferon Therapy - 11/18/05

Is Shorter Treatment with Peginterferon Alfa-2a (Pegasys) Plus Ribavirin Possible in HCV Genotype 1 'Super Responders'? - 11/14/05

Consensus Interferon in Combination with Gamma Interferon and/or Ribavirin Results in a Significant Virologic Response in Hepatitis C Genotype 1 Patients - 11/14/05


<--- Return to the 56th AASLD Main Page